Foghorn Therapeutics Inc.

NASDAQ:FHTX

Biotechnology

Healthcare
$1.79 +2.35%

+$0.10 today

Market cap
$107.33M
Beta
2.89
P/E (TTM)
-3.8
EPS (TTM)
-$1.08
52W Low $3.27High $6.95

Volume 0.53M

Average 0.15M

Balance Sheet

Inspect the capital base behind the business.

Assets

$198.10M

FY 2025 · Annual

-30.2% YoY

Liabilities

$306.60M

FY 2025 · Annual

-7.0% YoY

Equity

-$108.50M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents101.14M52.21M80.34M55.45M80.88M
Short-term Investments53.15M293.58M153.72M188.29M78.02M
Net Receivables300M0000
Inventory00000
Other Current Assets05.6M6.12M5.85M4.34M
Total Current Assets459.56M351.4M240.18M249.6M163.24M
Property, Plant & Equipment (Net)56.08M49.4M42.91M32.61M32.86M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets4.13M4.09M2.82M1.78M2M
Total Non-current Assets60.21M53.48M45.74M34.38M34.87M
Total Assets519.77M404.88M285.92M283.98M198.1M
Account Payables3.82M5.41M6.26M3.79M4.27M
Short-term Debt00000
Tax Payables00674K00
Deferred Revenue28.32M32.82M34.55M45.61M43.19M
Other Current Liabilities5.99M5.06M4.38M4.74M6.32M
Total Current Liabilities48.69M55.21M58.44M66.99M59.74M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)322.73M304M268.12M234.46M205.96M
Other Non-current Liabilities143K29K00556K
Total Non-current Liabilities374.21M349.57M304.67M262.52M246.87M
Total Liabilities422.9M404.77M363.11M329.51M306.6M
Common Stock4K4K4K6K6K
Retained Earnings(264.26M)(373.14M)(471.56M)(558.18M)(632.47M)
Accumulated OCI(10K)(3.99M)(826K)135K24K
Other Stockholders Equity00000
Minority Interest00000
Total Equity96.87M112K(77.19M)(45.53M)(108.5M)
Total Debt58.33M51.51M45.07M37.13M41.27M
Net Debt(42.8M)(707K)(35.26M)(18.32M)(39.61M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$88.9M
Short-term Investments$96.0M
Other Current$3.2M
Total Current Assets$188.1M
PP&E (Net)$32.1M
Long-term Investments$2.0M
Other Non-current$3.0K
Total Non-current Assets$34.1M
Total Assets$222.2M

Analysis

Selected assets total $222.2M for Latest. The largest visible component is Short-term Investments at $96.0M, about 43.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
3Initial statement of beneficial ownershipOct 5, 2026
SC 13G/ASC 13G/A filingOct 5, 2026
8-KCurrent reportOct 1, 2026

How much cash does FHTX have?

Foghorn Therapeutics Inc. (FHTX) reported $80.88M in cash and equivalents in fiscal 2025.

How much debt does FHTX carry?

Foghorn Therapeutics Inc. (FHTX) reported $41.27M of total debt, with net debt of -$39.61M.